This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

TRADE NEWS: Agilent Technologies Introduces Two New ScreenTape Assays To Optimize Next-Generation Sequencing Quality Control, Performance, Throughput

Agilent Technologies Inc. (NYSE: A) today introduced two new assays for the 2200 TapeStation system: the RNA ScreenTape and the D1000 ScreenTape assays. Both assays are essential for the quality control of samples in next-generation sequencing (NGS) workflow. They replace Agilent’s R6K and D1K ScreenTape assays.

The new RNA ScreenTape assay delivers qualitative and quantitative assessment of total RNA for both eukaryotic and prokaryotic samples, with a Bioanalyzer-like electropherogram and RNA Integrity Number equivalent (RIN e) quality score. The new D1000 ScreenTape assay builds on the success of the D1K ScreenTape, with closer alignment in sizing and quantification to the market-leading 2100 Bioanalyzer system.

“Next-generation sequencing has become an invaluable tool for life science researchers, and the key to achieving the highest-quality NGS results is the ability to monitor and ensure the quality of samples being prepared throughout the front-end process,” said Yvonne Linney, vice president and general manager of Agilent’s Life Science Solutions Division. “The 2200 TapeStation system is an ideal technology for this, providing a simplified, automated process for nucleic acid quality control. With enhanced performance, these new assays optimize quantification and sizing and improve RNA resolution.”

For more information about the new Agilent RNA ScreenTape and D1000 ScreenTape assays visit www.agilent.com/genomics/NGS-QC.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement company. The separation is expected to be completed in early November 2014.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs